<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>16153358</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Stiefel, Pablo</dc:author>
<dc:author>Miranda, María Luisa</dc:author>
<dc:author>Jiménez, Luis</dc:author>
<dc:author>Muñiz, Ovidio</dc:author>
<dc:author>Villar, José</dc:author>
<dc:author>Nieto, María Dolores</dc:author>
<dc:description xml:lang="en">BACKGROUND AND OBJECTIVE There is a high prevalence of diabetes in essential hypertensive patients, hence increasing the cardiovascular risk of these subjects. Our aim was to test the importance of a routine assessment of an oral glucose tolerance test (OGTT) in a sample of recently diagnosed essential hypertensives. PATIENTS AND METHOD We studied 270 recently diagnosed untreated hypertensives (56% males). We measured fasting lipids and plasma glucose and insulin at baseline and after OGTT. RESULTS 38.5% of the studied subjects had any abnormality of glucose metabolism, glucose intolerance (22.2%) and type 2 diabetes (12.2%) being the most common. An impaired fasting glucose was present in 4.1% of subjects. Patients with intolerance or type 2 diabetes had a worse plasma lipid profile, and those with impaired fasting glucose, a higher HOMA index. CONCLUSIONS The high incidence of glucidic abnormalities found in hypertensive patients signals a need to perform an OGTT test in them. This can lead to the implementation of strategies aimed at halting vascular impairment in hypertensives with type 2 diabetes and delay the development of type 2 diabetes in patients with glucose intolerance.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2005 Jul 02 </dc:date>
<dc:title xml:lang="es">Alteraciones del metabolismo glucídico en la hipertensión arterial esencial. Papel de la sobrecarga oral con glucosa.</dc:title>
<dc:title xml:lang="en">[Abnormal glycemic metabolism in essential hypertension. Role of the an oral glucose tolerance test].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
